Fitusiran Beneficial in Hemophilia A, B With or Without Inhibitors
Reduction in annualized bleeding rate seen compared with bypassing agents on demand and on-demand clotting factor concentrates
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.